Safety Evaluation of Ocular Drug Delivery Formulations: Techniques and Practical Considerations

@article{Short2008SafetyEO,
  title={Safety Evaluation of Ocular Drug Delivery Formulations: Techniques and Practical Considerations},
  author={Brian Short},
  journal={Toxicologic Pathology},
  year={2008},
  volume={36},
  pages={49 - 62}
}
  • B. Short
  • Published 1 January 2008
  • Medicine, Biology
  • Toxicologic Pathology
Development of new drug candidates and novel delivery techniques for treatment of ocular diseases has recently accelerated. Treatment of anterior-segment diseases has witnessed advances in prodrug formulations and permeability enhancers. Intravitreal, subconjunctival, and periocular routes of administration and sustained-release formulations of nanoparticles and microparticles, as well as nonbiodegradable and biodegradable implants to deliver drugs to the posterior segment of the eye, are… 
Advanced Formulation Approaches for Ocular Drug Delivery: State-Of-The-Art and Recent Patents
TLDR
This review discusses the different types of advanced formulations used for ocular delivery of therapeutics presenting the most recent patents according to the clinical applications.
Nanocarriers for ocular delivery for possible benefits in the treatment of anterior uveitis: focus on current paradigms and future directions
TLDR
The article explores the various polymers involved in the preparation of novel nanocarriers like polymeric nanoparticles, micelles, microemulsion, liposomes and cubosomes.
Strategies for modifying drug residence time and ocular bioavailability to decrease treatment frequency for back of the eye diseases
TLDR
An overview of emerging technologies for delivery of biologics to the back of the eye is presented, hampered by a multitude of factors, including patient education, translatability of in vitro/in vivo preclinical data to the clinic, and regulatory challenges associated with novel technologies.
Recent advances in ophthalmic drug delivery.
TLDR
The resurgence in interest to prolong and improve drug entry from topical administration is summarized, with a few approaches include mucoadhesives, viscous polymer vehicles, transporter-targeted prodrug design, receptor- targeted functionalized nanoparticles, iontophoresis, punctal plug and contact lens delivery systems.
Anterior eye segment drug delivery systems: current treatments and future challenges.
TLDR
This review covers the various physiological and anatomical barriers that exist for effective delivery to the targeted tissue of the eye, the pathological conditions of the anterior segment, and the unmet needs for treatment of these ocular diseases and reviews the novel delivery technologies that have the potential to maintain and/or improve the drug's therapeutic index.
Lipid based systems for ocular drug delivery: Effect of surface modification
TLDR
This review summarizes scientific results such as articles and patents that involve the potential application of lipid nanoparticles as platform for the ocular drug delivery.
Colloidal drug delivery system: amplify the ocular delivery
TLDR
It has been found that the novel delivery system have greater impact to maximize ocular drug absorption, and minimize systemic absorption and side effects.
Topical Drug Delivery to the Posterior Segment of the Eye: Addressing the Challenge of Preclinical to Clinical Translation
Topical delivery of therapeutics to the posterior segment of the eye remains the “holy grail” of ocular drug delivery. As an example, anti–vascular endothelial growth factor biologics, such as
A Novel Approach of Drug Localization through Development of Polymeric Micellar System Containing Azelastine HCl for Ocular Delivery
TLDR
A controlled release pH-sensitive ocular formulation capable of carrying the drug to the anterior section of the eye via topical delivery was successfully developed for the treatment of allergic conjunctivitis.
Pharmacokinetic aspects of retinal drug delivery
...
1
2
3
4
5
...

References

SHOWING 1-10 OF 44 REFERENCES
Novel approaches to ocular drug delivery.
TLDR
The development of prodrug formulations and permeability enhancers, sustained-release drug delivery devices, novel injectable medications and new and improved vectors for delivery of genes to all segments of the eye has greatly increased the chances of success in treating eye diseases.
Drug delivery methods for posterior segment disease
  • J. Hsu
  • Medicine, Biology
    Current opinion in ophthalmology
  • 2007
TLDR
Novel drug delivery systems involving nonbiodesgradable or biodegradable implants, microparticulates or nanoparticulate, liposomes, or transscleral iontophoresis may provide the solution for chronic conditions that require repeated local administration of drug.
Drug delivery from ocular implants
TLDR
Intraocular DDSs using a biodegradable implant may soon be successfully used to treat serious intraocular disorders.
Ocular drug delivery
TLDR
This review aims to outline the major routes of ocular drug delivery, including systemic, topical, periocular and intravitreal, and the pharmacokinetics, the disadvantages and the clinical relevance have been emphasised.
Intraocular implants for extended drug delivery: therapeutic applications.
Biodegradable microspheres for vitreoretinal drug delivery.
Recent progress in ocular drug delivery for posterior segment disease: emphasis on transscleral iontophoresis.
Pharmacokinetic and toxicity study of an intraocular cyclosporine DDS in the anterior segment of rabbit eyes.
TLDR
The Oculex DDS CsA device is effective in delivering long-term levels ofCsA to corneal tissues, without adverse effects, and should be considered for use in the prophylaxis and treatment ofCorneal transplant rejection in humans.
Ocular drug delivery targeting the retina and retinal pigment epithelium using polylactide nanoparticles.
TLDR
The presence of the NPs within the RPE cells 4 months after a single injection shows that a steady and continuous delivery of drugs can be achieved, and supports the idea that specific targeting of these tissues is feasible.
Evaluation of a delivery system providing long-term release of cyclosporine.
TLDR
The device produces sustained intravitreal levels of cyclosporine, which was associated with reversible toxic effects in the rabbit and well tolerated in primates, and is a promising new treatment for chronic uveitis.
...
1
2
3
4
5
...